Updated:
AMYLIN PHARMACEUTICALS INC
AMYLIN PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000881464, and its reported...
Overview
AMYLIN PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000881464, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2012-02-22, it reported annual revenue of USD 650,678,000; total assets of USD 1,870,199,000 for the fiscal period ended 2011-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- AMYLIN PHARMACEUTICALS INC
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0000881464
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2011USD | $650.7M | $1.9B | $99.9M | $88.3M | |
| FY2010USD | $668.8M | $1.5B | $164.5M | -$38.7M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 10-Q | Form 10-Q | ||
| SC 13G | — | AMYLIN PHARMACEUTICALS, INC. | |
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| DEF 14A | DEFINITIVE PROXY STATEMENT |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research AMYLIN PHARMACEUTICALS INC in Altss
Track this company’s investors, transactions and relationships in Altss.